The whole plant of Solanum lyratum THUNB (Solanaceae) is a renowned traditional Chinese medicine that has been used as anti-inflammatory, antitumor, antibacterial, and antioxidant agent. [1] [2] [3] [4] In our previous phytochemical studies, we reported isolation of several sesquiterpenoids, flavonoids, and amides, some of which showed significant cytotoxic activities. [5] [6] [7] [8] As part of our ongoing search for new natural compounds with biological activities, the ethanolic extract of S. lyratum was further investigated, which led to the isolation of three new 4-hydroxyisoflavans, named lyratin A (1), lyratin B (2), and lyratin C (3), together with a known 4-hydroxyisoflavan, 4,7,2Ј-trihydroxy-4Ј-methoxyisoflavan (4). On the basis of extensive spectroscopic analyses, the structures of the new compounds were elucidated. In addition, the isolated four 4-hydroxyisoflavans were screened for their anti-inflammatory activities with inhibitory rates of release of b-glucuronidase from polymorphonuclear leukocytes of rats in the range of 30.3-38.6% at 10 mM. Herein we report the isolation, structure elucidation and anti-inflammatory activities of these four 4-hydroxyisoflavans.
, which were in agreement with hydroxy and aromatic groups. The 1 H-NMR spectrum showed the presence of a pair of doublets at d H 3.57 (1H, dd, Jϭ11.0, 11.1 Hz) and 4.19 (1H, dd, Jϭ5.0, 11.0 Hz), a multiplet at d H 3.52 (1H, m), and a doublet at d H 5.45 (1H, d, Jϭ6.6 Hz). These signals were assignable to two H-2 protons, H-3, and H-4 protons of a 4-hydroxyisoflavan skeleton. The corresponding carbons were identified by heteronuclear multiple quantum coherence (HMQC) experiment as a methylene carbon at d C 65.8 (C-2) and two methine carbon atoms at d C 39.3 (C-3) and 77.4 (C-4). In the 1 H-NMR spectrum, further signals were observed that showed the presence of 7- 1H, s) ]. In the heteronuclear multiple bond correlation (HMBC) spectrum, the cross peaks from the proton at d H 9.59 to C-7, from the proton at d H 9.21 to C-4Ј, and from the proton at d H 8.31 to C-2Ј confirmed that three hydroxyl moieties were attached to C-7, C-4Ј, and C-2Ј, respectively. The long-range correlations from H-4 to C-2, C-3, C-5, C-9, and C-1Ј, from H-3 to C-2, C-10, C-1Ј, C-2Ј, and C-6Ј, as well as from H-2 to C-3, C-4, and C-1Ј indicated the presence of the C-ring. The position of the prenyl group was confirmed by HMBC experiment, which showed correlation between a vinylic proton H-2Љ of the prenyl substituent and C-3Ј, furthermore, the methylene protons H-1Љ of the prenyl substituent showed correlations with C-2Ј, C-3Ј, and C-4Ј. The proton H-6Ј showed correlations with C-2Ј, C-3Ј, C-4Ј, and C-3, while proton H-5Ј showed correlations with C-1Ј, C-3Ј, and C-4Ј. Thus the substitution in the B-ring was determined to be 2Ј,4Ј-dihydroxy-3Ј-g,g-dimethylallyl. The relative configuration of 1 was determined from rotating frame Overhauser enhancement spectroscopy (ROESY) data. In the ROESY spectrum, cross peaks were observed from H-3 to H-2 b and from H-4 to H-2 a , confirming that the relative configuration of H-3 and H-4 was trans. Furthermore, the absolute configurations of C-3 and C-4 of 1 were established from circular dichroism (CD) spectrum. In a previous paper, 9) it was reported that (3S,4R)-4-hydroxyisoflavan exhibits a negative Cotton effect at 220-250 nm and a positive Cotton effect at 250-300 nm, while (3R,4S)-4-hydroxyisoflavan showed positive and negative Cotton effects in the regions of 220-250 and 250-300 nm, respectively. Since the CD spectrum of 1 showed a negative Cotton effect at 239 nm and a positive Cotton effect at 285 nm, this suggests the absolute configurations of C-3 and C-4 as 3S, and 4R, respectively. On the basis of the above data and comprehensive 2D NMR experiments (HMQC and HMBC), the structure of compound 1 was identified as shown in Fig. 1 , which was cyclized with C-4Ј and C-2Љ by an ether linkage, as supported by corresponding HMBC experiment. The relative configuration of the stereogenic centers of 2 was the same as those in 1, as determined by the ROESY spectrum. Furthermore, based on the results of optical rotation and CD data, the absolute configurations of two chiral carbons of 2 were found in agreement with 1. Consequently, the structure of compound 2 was established as shown in Fig. 1 , named lyratin B.
Compound 3 was isolated and purified as a pale yellow gum, and the molecular formula was established as C 20 H 22 O 6 by HR-ESI-MS, which displayed a quasi-molecular ion at m/z 359.1490 [MϩH] ϩ . The IR spectrum exhibited absorption bands at 3433, 1611, 1552, and 1455 cm Ϫ1 , which corresponded to hydroxy and aromatic groups. The 1 H-and 13 C-NMR spectra of 3 were similar to those of 2 except for the absence of the double bond across C-3Љ/C-4Љ and the presence of an oxygenated methine proton [ . The long-range correlation between the proton at d H 5.09 and C-3Љ indicated that the hydroxy group was attached to C-3Љ. With the aid of the ROESY data, it was readily confirmed that the relative configuration of the protons at C-3 and C-4 was also trans. Additionally, the absolute configurations of C-3 and C-4 were assigned as 3S, 4R on the basis of its CD spectrum, which displayed a negative Cotton effect at 239 nm and a positive Cotton effect at 285 nm. 9) In this way, except for C-3Љ, the absolute configurations of all chiral centers of 3 were established. Thus the structure of compound 3 was determined as shown in Fig. 1 , named lyratin C.
The known compound was identified as 4,7,2Ј-trihydroxy-4Ј-methoxyisoflavan (4) by comparison of its physical and spectral data with those reported in the literature. 10) Compounds 1-4 and ginkgolide B were evaluated for anti-inflammatory activities using established methods, 11, 12) and the inhibitory rates of release of b-glucuronidase from polymorphonuclear leukocytes (PMNs) of rats were 31.7%, 38.6%, 30.3%, 35.4% and 50.2% respectively at 10 mM. Based on the bioassay results, it may be concluded that these compounds have inhibitory activities on the release of b-glucuronidase from rat PMNs induced by platelet activating-factor (PAF).
Experimental
General Experimental Procedures Optical rotations were recorded by Perkin-Elmer 241 polarimeter. UV spectra were obtained by Shimadzu UV-160 spectrophotometer. IR spectra were determined by Perkin-Elmer 683 infrared spectrometer with KBr disks. CD spectra were recorded by JASCO-815 CD spectrometer. ESI-MS were measured by Bruker Esquire 3000 Plus spectrometer. HR-ESI-MS were recorded by Micromess Q-Tof Global mass spectrometer. NMR spectra were obtained by Varian Unity BRUKER 400 at 400 MHz ( 1 H) and 100 MHz ( C-NMR data, see Table  1 . C-NMR data, see Table 1 . Anti-inflammatory Bioassays The effects of compounds 1-4 and ginkgolide B on the release of b-glucuronidate in rat PMNs induced by PAF in vitro were measured. Rat PMNs were incubated with vehicle or various concentrations of test compounds at 37°C for 15 min. Then, cytochalasin B (10 mmol l Ϫ1 ) was added. After 5 min, PAF (1 mmol l Ϫ1 ) was added prior to termination of the reaction. The supernatants of the reaction were incubated with phenolphthalein glucuronic acid (0.4 mmol l
Ϫ1
) at 37°C for 18 h. The absorbance was read at 550 nm then the inhibitory ratio was calculated. Ginkgolide B (Sigma; 98% pure) was used as positive control. 
